Brought to you by 
Gambro acquires Teraklin to expand intensive care business
01 Nov 2004
Executive Summary
Gambro AB (renal care and blood separation and handling technologies) has acquired Teraklin AG (focused on the treatment of acute liver failure) to extend its intensive care products business into extracorporeal liver support treatments.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Gambro acquires Teraklin to expand intensive care business
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice